This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Born, T L Articles by Feramisco, J R Search for Related Content PubMed PubMed Citation Articles by Born, T L Articles by Feramisco, J R

c-Myc cooperates with activated Ras to induce the cdc2 promoter.

Department of Medicine, University of California, San Diego, La Jolla 92093-0636.

ABSTRACT

Expression of c-myc with constitutively active mutants of the ras gene results in the cooperative transformation of primary fibroblasts, although the precise mechanism by which these genes cooperate is unknown. Since c-Myc has been shown to function as a transcriptional activator, we have examined the ability of c-Myc and activated Ras (H-RasV-12) to cooperatively induce the promoter activity of cdc2, a gene which is critical for cell cycle progression. Microinjection of expression constructs encoding H-RasV-12 and c-Myc along with a cdc2 promoter-luciferase reporter plasmid into quiescent cells led to an increase in cdc2 promoter activity approximately 30 h after injection, a period which coincides with the S-to-G2/M transition in these cells. Expression of H-RasV-12 alone weakly activated the cdc2 promoter, while expression of c-Myc alone had no effect. Mutants of c-Myc lacking either the leucine zipper dimerization domain or the phosphoacceptor site Ser-62 could not cooperate with H-RasV-12 to induce the cdc2 promoter. These mutants also lacked the ability to cooperate with H-RasV-12 to stimulate DNA synthesis. Deletion analysis identified a distinct region of the cdc2 promoter which was required for c-Myc responsiveness. Taken together, these observations suggest a mechanistic link between the molecular activities of c-Myc and Ras and induction of the cell cycle regulator Cdc2.

This article has been cited by other articles:

• Lee, S.-G., Su, Z.-Z., Emdad, L., Sarkar, D., Fisher, P. B. (2006). Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc. Natl. Acad. Sci. USA 103: 17390-17395 [Abstract] [Full Text]  
• Vaque, J. P., Navascues, J., Shiio, Y., Laiho, M., Ajenjo, N., Mauleon, I., Matallanas, D., Crespo, P., Leon, J. (2005). Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway. J. Biol. Chem. 280: 1112-1122 [Abstract] [Full Text]  
• Rylski, M., Welch, J. J., Chen, Y.-Y., Letting, D. L., Diehl, J. A., Chodosh, L. A., Blobel, G. A., Weiss, M. J. (2003). GATA-1-Mediated Proliferation Arrest during Erythroid Maturation. Mol. Cell. Biol. 23: 5031-5042 [Abstract] [Full Text]  
• Yun, J., Chae, H.-D., Choy, H. E., Chung, J., Yoo, H.-S., Han, M.-H., Shin, D. Y. (1999). p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor. J. Biol. Chem. 274: 29677-29682 [Abstract] [Full Text]  
• Ma, Y., Prigent, S. A., Born, T. L., Monell, C. R., Feramisco, J. R., Bertolaet, B. L. (1999). Microinjection of Anti-p21 Antibodies Induces Senescent Hs68 Human Fibroblasts to Synthesize DNA but not To Divide. Cancer Res. 59: 5341-5348 [Abstract] [Full Text]  
• Fujita, N., Furukawa, Y., Itabashi, N., Tsuboi, Y., Matsuda, M., Okada, K., Saito, T. (1999). Failure of cdc2 promoter activation and G2/M transition by ANG II and AVP in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 277: H515-H523 [Abstract] [Full Text]  
• Dang, C. V. (1999). c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. Mol. Cell. Biol. 19: 1-11 [Full Text]  
• Stevenson, L. E., Ravichandran, K. S., Frackelton, A. R. Jr. (1999). Shc Dominant Negative Disrupts Cell Cycle Progression in Both G0-G1 and G2-M of ErbB2-positive Breast Cancer Cells. Cell Growth Differ. 10: 61-71 [Abstract] [Full Text]  
• Braun-Dullaeus, R. C., Mann, M. J., Dzau, V. J. (1998). Cell Cycle Progression : New Therapeutic Target for Vascular Proliferative Disease. Circulation 98: 82-89 [Abstract] [Full Text]  
• Liu, Z.-J., Ueda, T., Miyazaki, T., Tanaka, N., Mine, S., Tanaka, Y., Taniguchi, T., Yamamura, H., Minami, Y. (1998). A Critical Role for Cyclin C in Promotion of the Hematopoietic Cell Cycle by Cooperation with c-Myc. Mol. Cell. Biol. 18: 3445-3454 [Abstract] [Full Text]  
• Facchini, L., Penn, L. Z. (1998). The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651 [Abstract] [Full Text]  
• Liu, Q., Yan, H., Dawes, N. J., Lu, Y., Zhu, H. (1998). Transcriptional Activation of the p34cdc2 Gene by cdc2 Promoter Binding Factor/Nuclear Factor-Y in Fetal Rat Ventricular Myocytes. Circ. Res. 82: 251-260 [Abstract] [Full Text]  
• Kaptein, J. S., Lin, C.-K. E., Wang, C. L., Nguyen, T. T., Kalunta, C. I., Park, E., Chen, F.-S., Lad, P. M. (1996). Anti-IgM-mediated Regulation of c-myc and Its Possible Relationship to Apoptosis. J. Biol. Chem. 271: 18875-18884 [Abstract] [Full Text]  
• Chen, H., Campisi, J., Padmanabhan, R. (1996). SV40 Large T Antigen Transactivates the Human cdc2 Promoter by Inducing a CCAAT Box Binding Factor. J. Biol. Chem. 271: 13959-13967 [Abstract] [Full Text]